Lazari Capital Management Inc. Acquires 2,064 Shares of UnitedHealth Group Incorporated $UNH

Lazari Capital Management Inc. raised its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 59.6% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,528 shares of the healthcare conglomerate’s stock after acquiring an additional 2,064 shares during the period. UnitedHealth Group makes up 0.6% of Lazari Capital Management Inc.’s investment portfolio, making the stock its 28th largest position. Lazari Capital Management Inc.’s holdings in UnitedHealth Group were worth $1,909,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of UNH. LFA Lugano Financial Advisors SA purchased a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $25,000. Sagard Holdings Management Inc. purchased a new stake in UnitedHealth Group during the second quarter valued at about $29,000. Islay Capital Management LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $31,000. Riggs Asset Managment Co. Inc. lifted its position in UnitedHealth Group by 69.4% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 43 shares during the last quarter. Finally, Kilter Group LLC bought a new position in UnitedHealth Group during the second quarter valued at approximately $34,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 0.2%

Shares of UNH opened at $334.55 on Thursday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36. The firm has a market capitalization of $303.05 billion, a price-to-earnings ratio of 17.46, a PEG ratio of 2.02 and a beta of 0.42. The firm’s 50-day moving average price is $329.85 and its 200-day moving average price is $321.87. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business’s revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the firm posted $7.15 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on UNH shares. UBS Group lifted their target price on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Piper Sandler lowered their target price on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday, October 28th. Jefferies Financial Group lifted their price target on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research note on Friday, October 17th. Wells Fargo & Company lifted their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Finally, Royal Bank Of Canada increased their price target on shares of UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a research report on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $385.75.

View Our Latest Analysis on UNH

About UnitedHealth Group

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.